Rheumatoid arthritis (RA) is a chronic inflammatory disorder that primarily affects the joints, leading to pain and disability. The introduction of biologic drugs has significantly improved ...
Expert Rev Pharmacoeconomics Outcomes Res. 2012;12(3):319-333. The most recent biologic therapy to receive marketing approval, tocilizumab, was evaluated in a 24-week, randomized, placebo ...
Drug Patients (n ... In the treatment of rheumatoid arthritis, switching among biologic agents has become established practice when patients fail to achieve a response, lose response or experience ...